Our News

Press Release May 11, 2026
CPTx appoints Edward Rebar as Chief Scientific Officer
Read More
Press Release May 4, 2026
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
Read More
Article January 23, 2026
Hendrik Dietz on “Making CAR T Truly Off the Shelf”
Read More
Press Release October 7, 2025
CPTx Unveils New Data at ESGCT Supporting ssDNA + LNP “Third Path” for In Vivo CAR-T
Read More
Article September 2, 2025
What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?
Read More
Press Release August 14, 2025
CPTx & NanoCell Therapeutics Project Awarded EU Funding for Innovative In Vivo CAR T Therapy with Immune-Silent Single-Stranded DNA
Read More
Article July 1, 2025
Opening new doors to precision medicine with single-stranded DNA (ssDNA): part 2
Read More
Article July 1, 2025
Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I
Read More
Article June 16, 2025
What role is precision medicine playing in transforming cancer treatment — and how are developers adapting?
Read More
Article June 9, 2025
Achieving Targeted Delivery with Nanoscale Systems
Read More
Article April 23, 2025
Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles
Read More
Paper January 14, 2025
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
Read More

Load more